The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 23, 2017

Primary Completion Date

November 4, 2017

Study Completion Date

January 16, 2018

Conditions

Xerostomia Due to Hyposecretion of Salivary GlandDiabetes Mellitus, Type 2

Interventions

DEVICE

artificial saliva spray (AS)

cross over design

OTHER

maritime throat spray (TT)

cross over design

Trial Locations (1)

Irwin Labs, University of Chieti, Chieti